H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b

H19 is a long non-coding RNA precursor of miR-675microRNA. H19 is increasingly described to play key roles in the progression and metastasis of cancers from different tissue origins. We have previously shown that the H19 gene is activated by growth factors and increases breast cancer cell invasion. In this study, we established H19/miR-675 ectopic expression models of MDA-MB-231 breast cancer cells to further investigate the underlying mechanisms of H19 oncogenic action. We showed that overexpression of H19/miR-675 enhanced the aggressive phenotype of breast cancer cells including increased cell proliferation and migration in vitro, and increased tumor growth and metastasis in vivo. Moreover, we identified ubiquitin ligase E3 family (c-Cbl and Cbl-b) as direct targets of miR-675 in breast cancer cells. Using a luciferase assay, we demonstrated that H19, through its microRNA, decreased both c-Cbl and Cbl-b expression in all breast cancer cell lines tested. Thus, by directly binding c-Cbl and Cbl-b mRNA, miR-675 increased the stability and the activation of EGFR and c-Met, leading to sustained activation of Akt and Erk as well as enhanced cell proliferation and migration. Our data describe a novel mechanism of protumoral action of H19 in breast cancer.

[1]  S. Ogawa,et al.  Deregulated Intracellular Signaling by Mutated c-CBL in Myeloid Neoplasms , 2010, Clinical Cancer Research.

[2]  A. Hochberg,et al.  The imprinted H19 gene as a tumor marker in bladder carcinoma. , 1995, Urology.

[3]  Michael Weber,et al.  H19 Antisense RNA Can Up-Regulate Igf2 Transcription by Activation of a Novel Promoter in Mouse Myoblasts , 2012, PloS one.

[4]  P. Heikkilä,et al.  H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. , 1995, The Journal of clinical endocrinology and metabolism.

[5]  E. Adriaenssens,et al.  Role of long non-coding RNA in cells: Example of the H19/IGF2 locus , 2013 .

[6]  Gabriel A. Cipolla,et al.  A non-canonical landscape of the microRNA system , 2014, Front. Genet..

[7]  Igor Jurisica,et al.  The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. , 2006, Cancer research.

[8]  Chaochun Liu,et al.  The imprinted H19 lncRNA antagonizes let-7 microRNAs. , 2013, Molecular cell.

[9]  Qin Chen,et al.  lncRNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI , 2014, The FEBS journal.

[10]  R. Ueda,et al.  Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. , 1995, Oncogene.

[11]  Jun Yu,et al.  Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. , 2010, Carcinogenesis.

[12]  T. Dupressoir,et al.  Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. , 2002, Carcinogenesis.

[13]  Lin Dong,et al.  Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases. , 2013, Biochimica et biophysica acta.

[14]  A. Hochberg,et al.  Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. , 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[15]  L. Hornez,et al.  Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells. , 2002, Experimental cell research.

[16]  A. Gabory,et al.  The H19 locus acts in vivo as a tumor suppressor , 2008, Proceedings of the National Academy of Sciences.

[17]  H. Soejima,et al.  Epigenetic and genetic alterations of the imprinting disorder Beckwith–Wiedemann syndrome and related disorders , 2013, Journal of Human Genetics.

[18]  M. Bartolomei,et al.  Parental imprinting of the mouse H19 gene , 1991, Nature.

[19]  Zhenggang Zhu,et al.  Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer , 2014, Oncotarget.

[20]  H. Hondermarck,et al.  A Novel H19 Antisense RNA Overexpressed in Breast Cancer Contributes to Paternal IGF2 Expression , 2008, Molecular and Cellular Biology.

[21]  F. Bertucci,et al.  Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.

[22]  Nan-Hyung Kim,et al.  Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma. , 2014, The Journal of investigative dermatology.

[23]  Ping Wang,et al.  The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. , 2014, Biochemical and biophysical research communications.

[24]  Yi Shen,et al.  Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. , 2006, Cancer research.

[25]  D. Monté,et al.  H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1* , 2005, Journal of Biological Chemistry.

[26]  Carme Camps,et al.  microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. , 2011, Cancer research.

[27]  Yunpeng Liu,et al.  Ubiquitin Ligase Cbl-b Is Involved in Icotinib (BPI-2009H)-Induced Apoptosis and G1 Phase Arrest of EGFR Mutation-Positive Non-Small-Cell Lung Cancer , 2013, BioMed research international.

[28]  Katsuki Ito,et al.  Loss of H19 imprinting in esophageal cancer. , 1996, Cancer research.

[29]  S. Corso,et al.  Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. , 2013, Cancer discovery.

[30]  R. Peek,et al.  Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells , 2013, PloS one.

[31]  T. Yeatman,et al.  miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma , 2013, Annals of Surgical Oncology.

[32]  B. Cullen,et al.  The imprinted H19 noncoding RNA is a primary microRNA precursor. , 2007, RNA.

[33]  S. Lottin,et al.  Steroid hormones modulate H19 gene expression in both mammary gland and uterus , 1999, Oncogene.

[34]  R. Toillon,et al.  TrkA overexpression enhances growth and metastasis of breast cancer cells , 2009, Oncogene.

[35]  Ivan Dikic,et al.  The Cbl interactome and its functions , 2005, Nature Reviews Molecular Cell Biology.

[36]  Ravi Salgia,et al.  CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases , 2010, PloS one.

[37]  S. Lottin,et al.  H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. , 1998, The American journal of pathology.

[38]  A. Hochberg,et al.  Oncofetal H19 RNA promotes tumor metastasis. , 2014, Biochimica et biophysica acta.

[39]  E. Dees,et al.  The product of the H19 gene may function as an RNA , 1990, Molecular and cellular biology.